Early detection

is key

LungLife AI is a developer of clinical diagnostic solutions designed to make a significant impact in the early detection of lung cancer, the deadliest cancer globally. Using a minimally invasive blood draw, our LungLB test is designed to deliver additional information to clinicians who are evaluating indeterminate lung nodules.

One in 16 people in the US will be diagnosed with lung cancer in their lifetime—and in many cases when it’s too late. We believe our simple blood test may afford those at risk a much better outcome through early diagnosis.”

Paul Pagano | CEO, LungLife AI

Our purpose
is simple

To Be a Driving Force

in the early detection of lung cancer.

To achieve our purpose, we are

dedicated to working collaboratively

with scientific and clinical partners.

Our LungLB® Test

is a blood-based tool that has been developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer. The test is performed in our CLIA certified laboratory in Thousand Oaks, California.

Order a Test